High Hurdle of Clinical Trials to Demonstrate Efficacy of Anticataractogenic Drugs

Publisher： Karger

E-ISSN： 1423-0267|214|6|390-398

ISSN： 0030-3755

Source： Ophthalmologica, Vol.214, Iss.6, 2000-10, pp. : 390-398

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Techniques to Reduce the Placebo Effect in Glaucoma Clinical Trials

By  

Ophthalmic Research, Vol. 54, Iss. 1, 2015-05 ,pp. : 3-5

Karger

Access to resources Recommend Favorite

Anticataractogenic Effect of an Extract of the Oyster Mushroom, Pleurotus ostreatus, in an Experimental Animal Model

By Isai M.   Elanchezhian R.   Sakthivel M.   Chinnakkaruppan A.   Rajamohan M.   Jesudasan C. Nelson   Thomas P. A.   Geraldine P.  

Current Eye Research, Vol. 34, Iss. 4, 2009-04 ,pp. : 264-273

Informa Healthcare

Access to resources Recommend Favorite

Average versus Highest Intraocular Pressure Analyses in Glaucoma Clinical Trials

By  

Ophthalmic Research, Vol. 49, Iss. 1, 2012-10 ,pp. : 49-51

Karger

Access to resources Recommend Favorite

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: From clinical trials to clinical practice

By Sickenberg Michel  

Seminars in Ophthalmology, Vol. 16, Iss. 4, 2001-12 ,pp. : 207-212

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of Occlusion Treatment in Amblyopia and Clinical Risk Factors Affecting the Results of Treatment

By Arikan Gul   Yaman Aylin   Berk A.  

Strabismus, Vol. 13, Iss. 2, 2005-06 ,pp. : 63-69

Informa Healthcare

Access to resources Recommend Favorite